BREAKING: Ebola Now Curable After Trials of Drugs in DRC, Say Scientists

0

WAEC 2022 Massive Recruitment for Graduates

Ebola can no longer be called an incurable disease, scientists have said, after two of four drugs being trialled in the major outbreak in the Democratic Republic of the Congo were found to have significantly reduced the death rate.

ZMapp, used during the massive Ebola epidemic in Sierra Leone, Liberia and Guinea, has been dropped along with Remdesivir after two monoclonal antibodies, which block the virus, had substantially more effect, said the World Health Organization and the US National Institute of Allergy and Infectious Diseases, which were co-sponsors of the trial.

The trial in the DRC, which started in November, has now been stopped. All Ebola treatment units will now use the two monoclonal antibody drugs.

READ ALSO  BREAKING : Queen Elizabeth tests positive for coronavirus

“From now on, we will no longer say that Ebola is incurable,” said Prof Jean-Jacques Muyembe, the director general of the Institut National de Recherche Biomédicale in DRC, which has overseen the trial.

Anthony Fauci, the director of the US NIAID, said the overall mortality of those given ZMapp in the trial in four centres was 49% while that of Remdesivir was 53%. A monoclonal antibody drug made by Regeneron had the lowest overall death rate, at 29%, while the monoclonal antibody 114 made by Ridgeback Biotherapeutics had a mortality rate of 34%.

Nigerian Army Recruitment Portal 2022 – DSSC Course (26 / 2022)

But the results in people who arrived at a treatment centre soon after they became sick, rather than staying at home, were even more impressive – with death rates of 24% on ZMapp, 33% with Remdesivir, 11% with 114 and just 6% with Regeneron’s drug.

READ ALSO  Rubber stamp Judiciary? APC lawmaker sacked by Appeal court remains Kwara Assembly member — KHA Speaker

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.